Skip to content

Clinical Efficacy of Stellate Ganglion Block Combined with Acupuncture of Myofascial Trigger Points in Patients with Insomnia Disorder

Clinical Efficacy of Stellate Ganglion Block Combined with Acupuncture of Myofascial Trigger Points in Patients with Insomnia Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120682
Enrollment
Unknown
Registered
2026-03-18
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

SM group:Stellate ganglion block combined with acupuncture targeting cervical-temporal myofascial trigger points

Sponsors

Shandong Second People's Hospital (Shandong Provincial ENT Hospital, Shandong Provincial Institute of Otolaryngology)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age 18–65 years, regardless of gender; 2.Meet the diagnostic criteria for insomnia disorder as defined by the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders (DSM), including difficulty falling asleep (>=30 minutes), light sleep, poor sleep quality, frequent awakenings (more than 2 times per night), early morning awakening, difficulty returning to sleep after waking, daytime fatigue and weakness, total daily sleep time =30 days; 3.Pittsburgh Sleep Quality Index (PSQI) score >7.

Exclusion criteria

Exclusion criteria: 1.Allergy to lidocaine; 2.Severe hepatic or renal impairment, hematological disorders (coagulation dysfunction: prothrombin time or activated partial thromboplastin time above the upper normal limit, international normalized ratio >=1.4, or platelet count 20 and a Hamilton Anxiety Rating Scale (HAMA) score >14; 4.Skin lesions or infections on the neck, temples, or face; 5.Pregnant, breastfeeding, or planning pregnancy; 6.Known alcoholism or dependence on other psychoactive substances; 7.Inability to comply with the treatment regimen or follow-up assessments; 8.Severe cognitive or language impairments.

Design outcomes

Primary

MeasureTime frame
Pittsburgh Sleep Quality Index;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index;Richards-Campbell Sleep Questionnaire;Rapid Eye Movement;Non-Rapid Eye Movement;Sleep efficiency;

Countries

China

Contacts

Public ContactZhang He

Shandong Second People's Hospital (Shandong Provincial ENT Hospital, Shandong Provincial Institute of Otolaryngology)

15169161036@163.com+86 531 8308 6289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026